May 2015 Issue

Pursuing Drugs for Mammary Cancer

Cornell researchers identify an inhibitor that seems to kill cancer cells while leaving healthy cells unaffected

Researchers studying feline mammary cancer at Cornell University College of Veterinary Medicine have set an ambitious agenda. They hope that their ongoing work will lead to better diagnosis, treatment and prevention of breast tumors in cats and humans. Much of their interest lies in how a novel class of drugs affects breast cell tumors. In a study funded by the Cornell Feline Health Center, Assistant Professor Gerlinde Van de Walle, DVM, Ph.D., and Associate Professor Scott Coonrod, Ph.D., both working at the Baker Institute for Animal Health, have identified a promising chemical, BB-Cl-amidine, that seems to kill off feline mammary cancer cells while leaving healthy cells unaffected.

To continue reading this entire article you must be a paid subscriber.

Subscribe to CatWatch Newsletter

Which foods are really safe for your cat? How can you painlessly end furniture scratching---for good? What is your cat telling you when she refuses to eat? Get the answers to these questions- and many more- when you subscribe now to CatWatch!

Already subscribe but haven't registered for all the benefits of the website? Click here.

Subscriber Log In

Forgot your password? Click Here.